You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 2, February 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (111)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic

Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men

A Randomized Controlled Trial

Harrison G. Pope, Jr, MD, MPH; Elena M. Kouri, PhD; James I. Hudson, MD, SM

Arch Gen Psychiatry. 2000;57:133-140.

Background  Field studies of illicit anabolic-androgenic steroid users suggest that some develop manic or aggressive reactions to these drugs—a potential public health problem. However, controlled laboratory evaluations of these effects remain limited.

Methods  In a randomized, placebo-controlled, crossover trial, we administered testosterone cypionate for 6 weeks in doses rising to 600 mg/wk and placebo for 6 weeks, separated by 6 weeks of no treatment, to 56 men aged 20 to 50 years. Psychiatric outcome measures included the Young Mania Rating Scale (YMRS), the Point Subtraction Aggression Paradigm (a computerized provocation test of aggression), the Aggression Questionnaire of Buss and Perry, the Symptom Checklist-90-R, daily diaries of manic and depressive symptoms, and similar weekly diaries completed by a "significant other" who knew the participant well.

Results  Testosterone treatment significantly increased manic scores on the YMRS (P=.002), manic scores on daily diaries (P=.003), visual analog ratings of liking the drug effect (P=.008), and aggressive responses on the Point Subtraction Aggression Paradigm (P=.03). Drug response was highly variable: of 50 participants who received 600 mg/wk of testosterone cypionate, 42 (84%) exhibited minimal psychiatric effects (maximum YMRS score, <10), 6 (12%) became mildly hypomanic (YMRS score, 10-19), and 2 (4%) became markedly hypomanic (YMRS score, >=20). The 8 "responders" and 42 "nonresponders" did not differ significantly on baseline demographic, psychological, laboratory, or physiological measures.

Conclusions  Testosterone administration, 600 mg/wk increased ratings of manic symptoms in normal men. This effect, however, was not uniform across individuals; most showed little psychological change, whereas a few developed prominent effects. The mechanism of these variable reactions remains unclear.


From the Biological Psychiatry Laboratory, McLean Hospital, Belmont; and Department of Psychiatry, Harvard Medical School (Drs Pope, Kouri, and Hudson), and Department of Biostatistics, Harvard School of Public Health (Dr Hudson), Boston, Mass.


RELATED ARTICLES

A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men With Hypogonadal Symptoms
Judith G. Rabkin, Glenn J. Wagner, and Richard Rabkin
Arch Gen Psychiatry. 2000;57(2):141-147.
ABSTRACT | FULL TEXT  

Time Course of Effects of Testosterone Administration on Sexual Arousal in Women
Adriaan Tuiten, Jack Van Honk, Hans Koppeschaar, Coen Bernaards, Jos Thijssen, and Rien Verbaten
Arch Gen Psychiatry. 2000;57(2):149-153.
ABSTRACT | FULL TEXT  

Testosterone in Psychiatry: Risks and Benefits
William R. Yates
Arch Gen Psychiatry. 2000;57(2):155-156.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low Free Testosterone Concentration as a Potentially Treatable Cause of Depressive Symptoms in Older Men
Almeida et al.
Arch Gen Psychiatry 2008;65:283-289.
ABSTRACT | FULL TEXT  

A Review of Body Image Influences on Men's Fitness Goals and Supplement Use
McCreary et al.
American Journal of Men's Health 2007;1:307-316.
ABSTRACT  

Testosterone and Aggression in a Simulated Crisis Game
McDermott et al.
The ANNALS of the American Academy of Political and Social Science 2007;614:15-33.
ABSTRACT  

Criminality Among Individuals Testing Positive for the Presence of Anabolic Androgenic Steroids.
Klotz et al.
Arch Gen Psychiatry 2006;63:1274-1279.
ABSTRACT | FULL TEXT  

The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
Handelsman
J. Clin. Endocrinol. Metab. 2006;91:1646-1653.
ABSTRACT | FULL TEXT  

Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Bloch et al.
Arch Gen Psychiatry 2006;63:450-456.
ABSTRACT | FULL TEXT  

Psychiatric Complications of Anabolic Steroid Abuse
Hall et al.
Psychosomatics 2005;46:285-290.
ABSTRACT | FULL TEXT  

Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men
Gray et al.
J. Clin. Endocrinol. Metab. 2005;90:3838-3846.
ABSTRACT | FULL TEXT  

Neuroendocrinology of nutritional infertility
Wade and Jones
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;287:R1277-R1296.
ABSTRACT | FULL TEXT  

The Effects of Pharmacologically Induced Hypogonadism on Mood in Healthy Men
Schmidt et al.
Arch Gen Psychiatry 2004;61:997-1004.
ABSTRACT | FULL TEXT  

Designer Androgens in Sport: When Too Much Is Never Enough
Handelsman
Sci Signal 2004;2004:pe41-pe41.
ABSTRACT | FULL TEXT  

Effects of Testosterone on Mood, Aggression, and Sexual Behavior in Young Men: A Double-Blind, Placebo-Controlled, Cross-Over Study
O'Connor et al.
J. Clin. Endocrinol. Metab. 2004;89:2837-2845.
ABSTRACT | FULL TEXT  

Tetrahydrogestrinone Is a Potent Androgen and Progestin
Death et al.
J. Clin. Endocrinol. Metab. 2004;89:2498-2500.
ABSTRACT | FULL TEXT  

Current Concepts in Anabolic-Androgenic Steroids
Evans
Am J Sports Med 2004;32:534-542.
ABSTRACT | FULL TEXT  

Medical aspects of drug use in the gym
DTB 2004;42:1-5.
ABSTRACT | FULL TEXT  

Anabolic Steroids
Kuhn
Recent Prog Horm Res 2002;57:411-434.
ABSTRACT | FULL TEXT  

Sex Hormones, Darwinism, and Depression
Niculescu and Akiskal
Arch Gen Psychiatry 2001;58:1083-1084.
FULL TEXT  

Violent Behaviors, Violent Victimization, and Doping Agents: A Normal Population Study of Adolescents
PEDERSEN et al.
J Interpers Violence 2001;16:808-832.
ABSTRACT  

Review of The Adonis Complex
Pope et al.
NEJM 2001;344:1557-1558.
FULL TEXT  

Testosterone's Effects Not Limited to Mood
Daly et al.
Arch Gen Psychiatry 2001;58:403-404.
FULL TEXT  

Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary Findings
Daly et al.
Arch Gen Psychiatry 2001;58:172-177.
ABSTRACT | FULL TEXT  

A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men With Hypogonadal Symptoms
Rabkin et al.
Arch Gen Psychiatry 2000;57:141-147.
ABSTRACT | FULL TEXT  

Testosterone in Psychiatry: Risks and Benefits
Yates
Arch Gen Psychiatry 2000;57:155-156.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.